mRNA |
VAF-347 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.01 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.01 |
mRNA |
BHG712 |
GDSC1000 |
pan-cancer |
AAC |
0.072 |
0.02 |
mRNA |
CI-1040 |
GDSC1000 |
pan-cancer |
AAC |
0.079 |
0.02 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.02 |
mRNA |
BRD-K02492147 |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.02 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.02 |
mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.02 |
mRNA |
Vinblastine |
GDSC1000 |
pan-cancer |
AAC |
-0.081 |
0.02 |
mRNA |
Bortezomib |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.02 |